Free Trial

Rani Therapeutics (RANI) Short Interest Ratio & Short Volume

Rani Therapeutics logo
$2.08 +0.04 (+1.96%)
(As of 11/22/2024 ET)

Rani Therapeutics Short Interest Data

Rani Therapeutics (RANI) has a short interest of 1.49 million shares, representing 7.18% of the float (the number of shares available for trading by the public). This marks a -41.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 548,896 shares to cover all short positions.

Current Short Interest
1,490,000 shares
Previous Short Interest
2,550,000 shares
Change Vs. Previous Month
-41.57%
Dollar Volume Sold Short
$3.41 million
Short Interest Ratio
0.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
53,410,000 shares
Float Size
20,750,000 shares
Short Percent of Float
7.18%
Today's Trading Volume
414,702 shares
Average Trading Volume
548,896 shares
Today's Volume Vs. Average
76%
Short Selling Rani Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Rani Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RANI Short Interest Over Time

RANI Days to Cover Over Time

RANI Percentage of Float Shorted Over Time

Rani Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,490,000 shares $3.41 million -41.6%7.2%0.9 $2.29
10/15/20242,550,000 shares $5.41 million +223.4%12.3%1.7 $2.12
9/30/2024788,600 shares $1.70 million -1.1%5.3%14.1 $2.16
9/15/2024797,600 shares $1.89 million +6.5%5.3%14.5 $2.37
8/31/2024749,100 shares $2.40 million +1.4%5.0%13.7 $3.20
8/15/2024738,700 shares $1.98 million -0.1%5.0%13.9 $2.68
7/31/2024739,700 shares $2.09 million -0.5%5.5%11.4 $2.83
7/15/2024743,600 shares $2.97 million -1.8%6.2%8.1 $3.99
6/30/2024757,200 shares $2.88 million +1.6%6.6%5.6 $3.80
6/15/2024745,400 shares $3.00 million -4.8%6.5%5.1 $4.03
5/31/2024783,200 shares $4.31 million -10.1%6.8%5.3 $5.50
5/15/2024871,200 shares $4.82 million -29.7%7.5%5.9 $5.53
4/30/20241,240,000 shares $7.91 million -27.9%10.9%8.6 $6.38
4/15/20241,720,000 shares $9.91 million -10.4%14.7%13.5 $5.76
3/31/20241,920,000 shares $5.97 million +3.2%16.7%23.7 $3.11
3/15/20241,860,000 shares $6.17 million +8.8%16.2%23.6 $3.32
2/29/20241,710,000 shares $6.40 million +2.4%15.2%16.6 $3.74
2/15/20241,670,000 shares $5.68 million No Change14.8%16.3 $3.40
1/31/20241,670,000 shares $5.78 million +9.9%14.8%16.1 $3.46
1/15/20241,520,000 shares $5.17 million +11.8%13.5%16.2 $3.40
12/31/20231,360,000 shares $4.52 million No Change12.1%13.9 $3.32
12/15/20231,360,000 shares $3.86 million +5.4%12.1%14.3 $2.84
11/30/20231,290,000 shares $2.55 million +8.4%7.6%15.7 $1.98
11/15/20231,190,000 shares $2.37 million -8.5%6.9%21.1 $1.99
10/31/20231,300,000 shares $2.55 million +17.1%7.6%24.7 $1.96
10/15/20231,110,000 shares $2.20 million +14.5%6.5%21 $1.98
9/30/2023969,500 shares $2.11 million +0.2%5.7%23.4 $2.18
9/15/2023967,300 shares $2.65 million -0.8%5.7%25.9 $2.74
8/31/2023975,000 shares $3.71 million +1.6%5.7%26.3 $3.80
8/15/2023959,400 shares $4.11 million -0.7%5.6%21.7 $4.28
7/31/2023965,700 shares $4.13 million -0.2%5.7%16.3 $4.28
7/15/2023967,500 shares $4.07 million +10.4%5.7%16.2 $4.21
6/30/2023876,100 shares $3.61 million +1.1%5.2%13.9 $4.12
6/15/2023866,700 shares $3.84 million -1.8%5.1%13.2 $4.43
5/31/2023882,500 shares $3.60 million +21.7%5.2%14.5 $4.08
5/15/2023724,900 shares $2.97 million +18.3%4.3%13.6 $4.10
4/30/2023612,700 shares $2.88 million +23.0%3.7%15.6 $4.70
4/15/2023498,200 shares $2.61 million +54.2%3.1%12 $5.24
3/31/2023323,200 shares $1.67 million +20.5%2.1%8.8 $5.16
3/15/2023268,200 shares $1.60 million -16.2%1.6%7.9 $5.95
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
2/28/2023320,000 shares $2.02 million -2.1%2.0%7.4 $6.30
2/15/2023326,800 shares $1.68 million -3.1%2.0%7.1 $5.13
1/31/2023337,400 shares $1.85 million -15.1%2.1%7.3 $5.49
1/15/2023397,600 shares $2.60 million -0.7%2.5%8.4 $6.54
12/30/2022400,200 shares $2.36 million -9.1%2.5%7.3 $5.90
12/15/2022440,400 shares $3.52 million +29.8%2.7%8.1 $8.00
11/30/2022339,400 shares $2.81 million +0.2%2.1%6.3 $8.28
11/15/2022338,900 shares $2.59 million -19.5%2.1%6.6 $7.64
10/31/2022420,900 shares $2.57 million +30.6%2.5%6.2 $6.10
10/15/2022322,400 shares $2.28 million +8.2%1.9%4.9 $7.08
9/30/2022298,100 shares $2.86 million +10.7%1.8%4.8 $9.58
9/15/2022269,400 shares $2.45 million -5.8%1.6%4.4 $9.11
8/31/2022286,100 shares $2.55 million -18.7%1.7%4.5 $8.90
8/15/2022351,800 shares $4.02 million +32.2%2.1%5.6 $11.44
7/31/2022266,100 shares $2.99 million +14.3%1.6%6.2 $11.25
7/15/2022232,900 shares $2.83 million +2.6%1.4%5.2 $12.14
6/30/2022227,000 shares $2.34 million +43.9%1.4%5.3 $10.33
6/15/2022157,700 shares $1.39 million -23.4%1.0%3.9 $8.83
5/31/2022205,800 shares $2.35 million +0.2%1.2%6.4 $11.40
5/15/2022205,400 shares $2.26 million +43.4%1.2%5.6 $11.00
4/30/2022143,200 shares $1.75 million -23.1%1.0%3.6 $12.23
4/15/2022186,100 shares $2.42 million -12.4%1.3%4.4 $13.00
3/31/2022212,400 shares $2.87 million -15.6%1.8%4.7 $13.50
3/15/2022251,600 shares $3.49 million +2.2%2.1%5 $13.89
2/28/2022246,100 shares $4.11 million -27.0%2.0%4.3 $16.69
2/15/2022337,300 shares $5.23 million -8.0%3.2%5.8 $15.50
1/31/2022366,800 shares $7.60 million -1.3%3.5%6 $20.73
1/15/2022371,800 shares $7.69 million -0.8%7.0%5.3 $20.67
12/31/2021374,700 shares $6.13 million No Change7.1%5.6 $16.35

RANI Short Interest - Frequently Asked Questions

What is Rani Therapeutics' current short interest?

Short interest is the volume of Rani Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,490,000 shares of RANI short. 7.18% of Rani Therapeutics' shares are currently sold short. Learn More on Rani Therapeutics' current short interest.

What is a good short interest ratio for Rani Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RANI shares currently have a short interest ratio of 1.0. Learn More on Rani Therapeutics's short interest ratio.

Which institutional investors are shorting Rani Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rani Therapeutics: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Rani Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.18% of Rani Therapeutics' floating shares are currently sold short.

Is Rani Therapeutics' short interest increasing or decreasing?

Rani Therapeutics saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 1,490,000 shares, a drop of 41.6% from the previous total of 2,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Rani Therapeutics' float size?

Rani Therapeutics currently has issued a total of 53,410,000 shares. Some of Rani Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rani Therapeutics currently has a public float of 20,750,000 shares.

How does Rani Therapeutics' short interest compare to its competitors?

7.18% of Rani Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Rani Therapeutics: Pyxis Oncology, Inc. (13.30%), Passage Bio, Inc. (3.21%), Foghorn Therapeutics Inc. (3.93%), Cartesian Therapeutics, Inc. (17.19%), Aquestive Therapeutics, Inc. (11.12%), Canopy Growth Co. (9.77%), KalVista Pharmaceuticals, Inc. (15.90%), Akebia Therapeutics, Inc. (6.80%), Larimar Therapeutics, Inc. (4.26%), Tango Therapeutics, Inc. (14.56%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Rani Therapeutics stock?

Short selling RANI is an investing strategy that aims to generate trading profit from Rani Therapeutics as its price is falling. RANI shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Rani Therapeutics?

A short squeeze for Rani Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RANI, which in turn drives the price of the stock up even further.

How often is Rani Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RANI, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:RANI) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners